Get the Stockscreener App
196.33
0.11%
0.21
After Hours:
196.33
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $196.33, with a volume of 758.94K.
It is up +0.11% in the last 24 hours and up +1.25% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$196.12
Open:
$196.08
24h Volume:
758.94K
Relative Volume:
0.36
Market Cap:
$55.94B
Revenue:
$21.84B
Net Income/Loss:
$1.68B
P/E Ratio:
33.68
EPS:
5.8293
Net Cash Flow:
$2.67B
1W Performance:
+0.38%
1M Performance:
+1.25%
6M Performance:
+15.51%
1Y Performance:
-13.94%
1-Day Range:
$194.87
$197.24
1-Week Range:
$194.82
$198.10
52-Week Range:
$162.29
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
196.33 | 55.88B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
577.81 | 204.60B | 9.61B | 2.77B | 2.27B | 7.555 |
|
ALC
Alcon Inc
|
80.38 | 39.38B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.76 | 35.68B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.13 | 34.85B | 27.43B | 1.27B | 1.01B | 1.5829 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Franklin Lakes OKs affordable housing on Becton Dickinson site - Bergen Record
Becton Dickinson (BDX): Evaluating Valuation After New Immunology Partnership with University of Pennsylvania - Yahoo Finance UK
BD faces hernia mesh lawsuit from Tela Bio - MassDevice
Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly - Benzinga
Trust Co. of Vermont Lowers Stake in Becton, Dickinson and Company $BDX - MarketBeat
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly - Reuters
IV Dressing Market Set for Dynamic Rise with Key Players Becton, - openPR.com
Is Becton Dickinson and Company stock a safe haven asset2025 Momentum Check & Accurate Trade Setup Notifications - ulpravda.ru
Becton Dickinson Faces Antitrust Suit Over Hernia Mesh Products - Bloomberg Law News
BECTON DICKINSON & CO ($BDX) CEO 2025 Pay Revealed - Quiver Quantitative
Form DEF 14A BECTON DICKINSON & CO For: Dec 12 - StreetInsider
Becton Dickinson, University of Pennsylvania partner on human immune profiling - TipRanks
Becton, Dickinson, University of Pennsylvania to Collaborate on Immune Profiling - 富途牛牛
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry - Finviz
Inside the 1,000-person immune study aiming to decode disease defenses - Stock Titan
Insider Sell: Michael Garrison Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
BECTON DICKINSON Executive Sells Shares Under Trading Plan - TradingView — Track All Markets
VP Garrison Sells 629 ($123.3K) Of Becton Dickinson & Co [BDX] - TradingView — Track All Markets
Can Becton Dickinson and Company (BOX) stock reach $200 price targetBear Alert & Verified Momentum Stock Alerts - Bollywood Helpline
The Magnificent 7 Are So Yesterday. These Are AI’s Next Big Winners - Forbes
RBC Capital Raises Becton Dickinson (BDX) Price Target to $210 | - GuruFocus
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $210 - 富途牛牛
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Cardinal Capital Management Inc. Grows Holdings in Becton, Dickinson and Company $BDX - MarketBeat
These Surging Dividend Stocks Are the Next AI Winners and Wall Street Hates Them - Investing.com
BD Expands BD MAX System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Finviz
Becton, Dickinson Expands Infection Diagnostics Offerings in Europe - marketscreener.com
BD expands diagnostic offerings with new IVDR-certified assays - Investing.com
Bd expands bd max(tm) system menu in partnership with Certest Biotec - marketscreener.com
Surprise Proposal For Part Of Becton Dickinson Site Shakes Up Franklin Lakes Housing Talks - dailyvoice.com
Bd Expands Bd Max™ System Menu In Partnership With Certest Biotec - TradingView — Track All Markets
BD expands diagnostic offerings with new IVDR-certified assays By Investing.com - Investing.com UK
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - marketscreener.com
Becton, Dickinson and Company Expands BD Max System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - marketscreener.com
YieldBoost BDX From 2.1% To 5.9% Using Options - Nasdaq
Farmers Trust Co. Purchases New Stake in Becton, Dickinson and Company $BDX - MarketBeat
Lazard Asset Management LLC Acquires 654,930 Shares of Becton, Dickinson and Company $BDX - MarketBeat
What Does Wall Street See for Becton, Dickinson's Q3? - AOL.com
Benjamin Edwards Inc. Increases Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Banque Transatlantique SA Has $2.83 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety - GlobeNewswire
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity - Yahoo Finance
Waters-Becton, Dickinson deal deadline expires in the US - MLex
Waters-Becton-Dickinson deal receives antitrust clearance in the US - MLex
Becton, Dickinson Reaches Analyst Target Price - Nasdaq
Becton Dickinson Shares Gain on Strategic Optimism and Product Launches - Ad-hoc-news.de
Morgan Stanley Highlights Positive Outlook for Becton, Dickinson (BDX) and the MedTech Sector - Finviz
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.60 Million Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by Cary Street Partners Financial LLC - MarketBeat
Jefferies Adjusts PT on Becton, Dickinson and Co. to $220 From $215, Maintains Buy Rating - marketscreener.com
Jefferies raises Becton Dickinson stock price target to $220 on deal implications By Investing.com - Investing.com South Africa
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):